Work

Abstract A113: Micvotabart pelidotin, a non-cellular targeting ADC, remodels the tumor microenvironment in tumors from participants in a phase 1 dose escalation study

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a113

Authors: Sara Lewandowski, Justin Trickett, Eugene Lurie, Krystal Watkins, Anthony W. Tolcher, Katherine Clifton, Benedito A. Carneiro, Jason T. Henry, Judy Wang, Shiraj Sen, Nuria Kotecki, Sylvie Rottey, Jean-Pascal Machiels, Hongwei Wang, Marsha Crochiere

Institutions: Washington University in St. Louis, Brown University, HealthONE, Florida Cancer Specialists & Research Institute, Institut Jules Bordet, Ghent University Hospital, Cliniques Universitaires Saint-Luc

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415447315

Cites:

Cited by:

Related to: